X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
male (17) 17
female (16) 16
middle aged (15) 15
rheumatology (13) 13
index medicus (12) 12
adult (11) 11
aged (10) 10
treatment outcome (8) 8
infliximab (6) 6
adalimumab (5) 5
adolescent (5) 5
antibodies, monoclonal, humanized - therapeutic use (5) 5
medicine & public health (5) 5
prospective studies (5) 5
spain (5) 5
uveitis (5) 5
antibodies, monoclonal - adverse effects (4) 4
antirheumatic agents - therapeutic use (4) 4
classification (4) 4
drug therapy, combination (4) 4
immunosuppressive agents - therapeutic use (4) 4
registries (4) 4
rheumatoid arthritis (4) 4
therapy (4) 4
tumor necrosis factor-alpha - antagonists & inhibitors (4) 4
uveitis - drug therapy (4) 4
analysis (3) 3
ankylosing-spondylitis (3) 3
arthritis, rheumatoid - drug therapy (3) 3
care and treatment (3) 3
child (3) 3
cross-sectional studies (3) 3
drug resistance (3) 3
efficacy (3) 3
etanercept (3) 3
necrosis-factor-alpha (3) 3
posterior uveitis (3) 3
rheumatoid-arthritis (3) 3
risk factors (3) 3
safety (3) 3
tocilizumab (3) 3
young adult (3) 3
abridged index medicus (2) 2
aged, 80 and over (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antirheumatic agents - adverse effects (2) 2
aqueous-humor (2) 2
arthritis (2) 2
arthritis, psoriatic - drug therapy (2) 2
behcet syndrome - drug therapy (2) 2
behcet's disease (2) 2
belimumab (2) 2
biological products - adverse effects (2) 2
biological products - therapeutic use (2) 2
cardiovascular diseases - epidemiology (2) 2
child, preschool (2) 2
cohort studies (2) 2
comorbidity (2) 2
disease (2) 2
disease-activity index (2) 2
drug administration schedule (2) 2
drug therapy (2) 2
fibromyalgia (2) 2
follow-up studies (2) 2
glucocorticoids - administration & dosage (2) 2
glucocorticoids - therapeutic use (2) 2
immunoglobulin g - therapeutic use (2) 2
immunosuppressive agents - adverse effects (2) 2
impact (2) 2
inflammation (2) 2
long-term efficacy (2) 2
manifestations (2) 2
medical research (2) 2
medicine (2) 2
medicine, experimental (2) 2
methotrexate (2) 2
multicenter (2) 2
noninfectious uveitis (2) 2
ophthalmology (2) 2
physiological aspects (2) 2
prednisone - therapeutic use (2) 2
prevalence (2) 2
receptors, tumor necrosis factor - therapeutic use (2) 2
risk (2) 2
severity of illness index (2) 2
sjogren's syndrome - complications (2) 2
sjogren's syndrome - epidemiology (2) 2
sjogren's syndrome - physiopathology (2) 2
spain - epidemiology (2) 2
spondylarthropathies - drug therapy (2) 2
standardization (2) 2
systemic lupus erythematosus (2) 2
time factors (2) 2
uveitis - etiology (2) 2
activation (1) 1
actuarial analysis (1) 1
adalimumab - adverse effects (1) 1
adalimumab - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Gomez-Reino, Juan J and Carmona, Loreto and Erra, Alba and Marsal, Sara and Castro, Mónica Fernández and Mulero, Juan and Andreu, Jose Luis and Gómez, Manuel Rodríguez and Padro, Marta Larrosa and Casado, Enrique and Leonor, Elena and Alierta, Sirvent and Reina, Delia and Gómez, Carmen García and Ibañez, Beatriz Joven and Delgado, Patricia Carreira and Hernández, Ma. Victoria and Loza, Estibaliz and Ruiz, Alberto Alonso and Itzazelaia, Esther Uriarte and Zarza, Lucia Pantoja and Aransay, Ma. Valvanera Pinillos and Hernández, Teresa Mariné and de Vicuña Pinedo, Rosario García and García, Ana Ma. Ortiz and Álvaro, Isidoro González and Laffon, Armando and Álvaro-Gracia, Jose Ma and López, César Díaz and de La Serna, Arturo Rodríguez and Cortina, Eduardo Loza and Oyarzabal, Ma. Victoria Irigoyen and Garnica, Inmaculada Ureña and Cagigal, Virginia Coret and Casasempere, Paloma Vela and Pascual, Eliseo and Serrano, Miquel Ángel Belmonte and Fabregat, Juan Beltran and Lerma, Juan José and Graña, Myriam Liz and Gómez-Reino, Juan José and Aizen, Saul Mario Gelman and Monge, Elena Ciruelo and Muriel, Eva Tomero and García, Juan Carlos Cobeta and Cuenca, Encarnación Saiz and Muñoz, José Galvez and de La Torre, Gerardo Iglesias and Pardo, Rosa Roselló and Galeano, Carlos Vázquez and de Diego, Juan Pablo Valdazo and Marsá, Xavier Tena and Santamaría, Vera Ortiz and Prada, Manuel Fernández and Piqueras, José Antonio and Tornero, Jesús and Méndez, Laura Cebrián and Carreño, Luis and Borras, Juan José García and Ruiz, Francisco Javier Manero and Busquets, Manel Pujol and Duran, Josep Granados and Cuadra, Jose Luis and Tevar, F. Javier Paulino and Huertas, Marcos Paulino and Maiz, Olga and Barastay, Estibaliz and Figueroa, Manuel and Torres, Carmen and Coro, Montserrat Corteguera and Lozano, Carlos Rodríguez and Hernández, Félix Francisco and Fernández, Iñigo Rua Figueroa and Martín, Oscar Illera and Zea Mendoza, Antonio C and de La Peña Lefebvre, Paloma García and Expósito, Marta Valero and Aznar, Emilia and Gutiérrez, Ricardo and Valenciano, Ana Cruz and Echeverria, Manuel Crespo and Del Pozo, Félix Cabero and Jimeno, Ma. Teresa Ruiz and Aresté, Jordi Fiter and Poch, Luis Espadaler and Carasa, Juan Carlos Vesga and Quintana, Eduardo Cuende and Andrada, Sagrario Sánchez and Valverde, Vicente Rodríguez and Amaro, Ivan Ferraz and García, Tomas González and Marenco, José Luis and Rejón, Eduardo and Estevez, Eduardo Collantes and Castro Villegas, M. Carmen and Hernández, Blanca and de Oca Mercader, José V. Montes and Sarabia, Federico Navarro and de Miera, Francisco Javier Toyos Saenz and Fernández-Cid, Carlos Marras and ... and BIOBADASER Grp and BIOBADASER Group
Arthritis Research and Therapy, ISSN 1478-6354, 01/2006, Volume 8, Issue 1, pp. R29 - R29
Journal Article
Arthritis Care & Research, ISSN 2151-464X, 01/2017, Volume 69, Issue 1, pp. 38 - 45
Journal Article
Farmacia Hospitalaria, ISSN 1130-6343, 2015, Volume 39, Issue 3, pp. 161 - 170
Objective: To estimate the cost-effectiveness of belimumab in patients with systemic lupus erythematosus (SLE) presenting positive biomarkers and active... 
Economic model | Systemic lupus erythematosus | Cost-effectiveness | Belimumab
Journal Article
Journal Article
by Atienza‐Mateo, Belén and Martín‐Varillas, José Luis and Calvo‐Río, Vanesa and Demetrio‐Pablo, Rosalía and Beltrán, Emma and Sánchez‐Bursón, Juan and Mesquida, Marina and Adan, Alfredo and Hernández, María Victoria and Hernández‐Garfella, Marisa and Valls‐Pascual, Elia and Martínez‐Costa, Lucía and Sellas‐Fernández, Agustí and Cordero‐Coma, Miguel and Díaz‐Llopis, Manuel and Gallego, Roberto and García‐Serrano, José L and Ortego‐Centeno, Norberto and Herreras, José M and Fonollosa, Alejandro and Garcia‐Aparicio, Ángel M and Maíz‐Alonso, Olga and Blanco, Ana and Torre‐Salaberri, Ignacio and Fernandez‐Espartero, Cruz and Jovaní, Vega and Peiteado, Diana and Pato, Esperanza and Cruz, Juan and Férnandez‐Cid, Carlos and Aurrecoechea, Elena and García‐Arias, Miriam and Castañeda, Santos and Caracuel‐Ruiz, Miguel A and Montilla‐Morales, Carlos A and Atanes‐Sandoval, Antonio and Francisco, Félix and Insua, Santos and González‐Suárez, Senen and Sanchez‐Andrade, Amalia and Gamero, Fernando and Linares Ferrando, Luis F and Romero‐Bueno, F and García‐González, A. Javier and González, Raquel Almodóvar and Muro, Enrique Minguez and Carrasco‐Cubero, Carmen and Olive, Alejandro and Prior, Águeda and Vázquez, Julio and Ruiz‐Moreno, Oscar and Jiménez‐Zorzo, Fernando and Manero, Javier and Muñoz Fernandez, Santiago and Fernández‐Carballido, Cristina and Rubio‐Romero, Esteban and Pages, Fred Antón and Toyos‐Sáenz de Miera, Francisco J and Martinez, Myriam Gandia and Díaz‐Valle, David and López Longo, Francisco J and Nolla, Joan M and Álvarez, Enrique Raya and Martínez, Marcelino Revenga and González‐López, Julio José and Rodríguez‐Cundin, Paz and Hernández, José L and González‐Gay, Miguel A and Blanco, Ricardo
Arthritis & Rheumatology, ISSN 2326-5191, 12/2019, Volume 71, Issue 12, pp. 2081 - 2089
Objective To compare the efficacy of infliximab (IFX) versus adalimumab (ADA) as a first‐line biologic drug over 1 year of treatment in a large series of... 
Journal Article
Journal of Clinical Lipidology, ISSN 1933-2874, 2017, Volume 11, Issue 3, pp. 749 - 756.e3
Journal Article
Clinical and experimental rheumatology, ISSN 0392-856X, 2016, Volume 34, Issue 6, pp. S34 - 40
Journal Article
Clinical and Experimental Rheumatology, ISSN 0392-856X, 2017, Volume 35, Issue 3, pp. 28 - 34
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 10/2010, Volume 37, Issue 10, pp. 2110 - 2117
Journal Article
Seminarios de la Fundacion Espanola de Reumatologia, ISSN 1577-3566, 01/2010, Volume 11, Issue 1, pp. 2 - 6
SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, osteitis) encompasses a group of osteoarticular manifestations, especially hyperostosis in the... 
Tumor necrosis factor alpha blockers | Synovitis Acne Pustulosis Hyperostosis Osteitis syndrome | Palmoplantar pustulosis
Journal Article
17.